Cases 71 - 80 of 213
Figueroa v. GlaxoSmithKline LLC et al
as 9:2021cv80508
Defendant:
Hikma Pharmaceuticals International, Ltd., Hi-Tech Pharmacal Co., Inc., Apotex Corportion and others
Plaintiff:
Rafael Figueroa
Cause Of Action: 28 U.S.C. § 1332
STARBOARD VALUE AND OPPORTUNITY C LP et al v. PERRIGO COMPANY PLC et al
as 2:2021cv03511
Plaintiff:
STARBOARD VALUE AND OPPORTUNITY C LP, STARBOARD LEADERS KILO LLC, STARBOARD VALUE AND OPPORTUNITY S LLC and others
Defendant:
PERRIGO COMPANY PLC, JUDY BROWN and JOSEPH PAPA
Figueroa v. GlaxoSmithKline LLC et al
as 3:2021cv01080
Defendant:
Hi-Tech Pharmacal Co., Inc., Apotex Corportion, McKesson Corporation and others
Plaintiff:
Rafael Figueroa
Cause Of Action: 28 U.S.C. § 1332
Peebles v. Boehringer Ingelheim Pharmaceutcals, Inc. et al
as 9:2021cv80106
Defendant:
PAI Holdings, LLC, formerly known as Pharmaceutical Associates, Inc., Heritage Pharmaceuticals, Inc., Novitium Pharma, LLC and others
Plaintiff:
Michael Edward Peebles
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Nowak et al v. Boehringer Ingelheim et al
as 9:2021cv80095
Defendant:
Sun Pharmaceutical Industries, Inc., McKesson Corporation, L. Perrigo Co. and others
Plaintiff:
Marian Nowak and Frank Nowak
Cause Of Action: 28 U.S.C. § 1332
Kirk v. Sanofi-Aventis U.S. LLC et al
as 9:2021cv80033
Defendant:
Sun Pharmaceutical Industries, Inc., Chattem, Inc., Sanofi S.A. and others
Plaintiff:
Tracey Kirk
Cause Of Action: 28 U.S.C. § 1332
Chenois v. Boehringer Ingelheim Pharmaceuticals, Inc et al
as 9:2021cv80003
Defendant:
Chattem, Inc., Wockhardt, Ltd., Apotex Inc. and others
Plaintiff:
Rita Chenois
Cause Of Action: 28 U.S.C. § 1332
Caldwell v. Sanofi-Aventis U.S. LLC et al
as 9:2021cv80004
Defendant:
AmerisourceBergen Corporation, Perrigo Company, L. Perrigo Co. and others
Plaintiff:
Jennifer Caldwell
Cause Of Action: 28 U.S.C. § 1332
Boyd v. Boehringer Ingelheim Pharmaceuticals, Inc et al
as 9:2020cv82479
Defendant:
Chattem, Inc., Ajanta Pharma Ltd., Aurobindo Pharma, Ltd. and others
Plaintiff:
Bobby R Boyd
Cause Of Action: 28 U.S.C. § 1332
Munt v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 9:2020cv82442
Defendant:
Chattem, Inc., Aurobindo Pharma, Ltd., Sanofi S.A. and others
Plaintiff:
Daniel Munt
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
